Evandro de Azambuja, MD, PhD· @E_de_Azambuja · X·· 21 hours agoScore70
Body
Anbenitamab + HB1801 has better PFS than THP as first line therapy (control arm did poorly 14.3 mos)
#ESMO26
#ESMOAmbassadors
#ESMOcommunity
@myESMO
23 views · 0 likes · 0 reposts · 0 replies
Conference abstracts
LBA15matched by Proffered paper 2: Breast cancer, early and advanced stage
Anbenitamab plus albumin-bound docetaxel in patients (pts) with HER2-positive advanced breast cancer (BC): A randomized phase III study
https://esmocongress.esmo.orgLBA80matched by Rapid oral 1: Gastrointestinal tumour, upper digestive
Anbenitamab plus chemotherapy for previously treated HER2-positive gastric or gastroesophageal carcinomas (GC/GEJC): Updated overall survival (OS) analysis of KC-WISE
https://esmocongress.esmo.orgSource: Evandro de Azambuja, MD, PhD · x.com